Proprietary master cell bank of fibroblast-based spheroids product candidate, CYWC628, completed in accordance with Good Manufacturing Practices ...

Data demonstrated multiple clinical benefits beyond linear growth — NDA supported by data from three randomized, double-blind ...

How cardiac cell fates are specified during heart development remains elusive. This study identifies a level-dependent role ...

FibroBiologics and Charles River have announced the completion of FibroBiologics’ master cell bank for a product that will be evaluated for the treatment of diabetic foot ulcers and other chronic ...

Backed by advanced in vitro and in vivo research, Pureblome™ promotes overall skin regeneration through a dual action ...

In accordance with the NMPA approval, Gyre intends to pursue an adaptive Phase 2/3 clinical trial design, combining dose exploration with efficacy confirmation, to efficiently evaluate pirfenidone's ...

The Arkansas Integrative Metabolic Research Center will explore the potential of a novel, artificially designed, hybrid growth factor to regulate the metabolism of fat and cancer cells.

Rutgers Health researchers have discovered that networks of misplaced immune cells drive an aggressive lung disease, ...

For millions of people, losing muscle isn't just about weakness; it's about losing independence. Whether caused by Duchenne ...